Friday, July 10, 2026

Drug profile · INN

hydroxystilbamidine isethionate

hydroxystilbamidine isethionate (HYDROXYSTILBAMIDINE ISETHIONATE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — hydroxystilbamidine isethionate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

hydroxystilbamidine isethionate (HYDROXYSTILBAMIDINE ISETHIONATE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN hydroxystilbamidine isethionate
Brand HYDROXYSTILBAMIDINE ISETHIONATE
Mechanism DNA inhibitor
Target DNA
Route INJECTION
Formulation INJECTABLE

Mechanism of action

DNA inhibitor

Primary target: DNA

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. acyclovir Human herpesvirus 1 DNA polymerase inhibitor
  2. acyclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  3. azacitidine Antineoplastic and immunomodulating agents (L01)
  4. bleomycin sulfate DNA inhibitor
  5. busulfan Antineoplastic and immunomodulating agents (L01)
  6. capecitabine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is hydroxystilbamidine isethionate?

hydroxystilbamidine isethionate (HYDROXYSTILBAMIDINE ISETHIONATE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for hydroxystilbamidine isethionate?

HYDROXYSTILBAMIDINE ISETHIONATE is a marketed brand name for hydroxystilbamidine isethionate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of hydroxystilbamidine isethionate?

hydroxystilbamidine isethionate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.